HIGHLIGHTS
- who: Lanyu Li et al. from the Department of Obstetrics and Gynecology, Central Hospital Affiliated to Shandong First Medical University, Jinan, China have published the Article: Exploration of the Molecular Mechanism of Danzhi Xiaoyao Powder in Endometrial Cancer through Network Pharmacology, in the Journal: Evidence-Based Complementary and Alternative Medicine 0.4 mg/mL of 13/06/2022
- what: In this study active components and potential targets of DXP were obtained from public databases. These reports combined with this research provide evidence for This study provides an effective drug for the treatment of EC.
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.